Clinical trial
Evaluation of the Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Administered With or Without Yellow Fever Vaccine in US Adults.
NCT01488890 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Administered With or Without Yellow Fever Vaccine in US Adults.
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 6, 2011
- Completion date
- September 27, 2013
- Enrollment
- 390 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
dengue, dengue fever, dengue hemorrhagic fever, yellow fever